FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Taiho Reports Unfavorable DMD Drug Data

[ Price : $8.95]

Taiho Pharmaceutical reports disappointing data from its Phase 3 extension study of TAS-205 (pizuglanstat) in patients with Duchen...

FDA Urged to Expand Real-World Data Use

[ Price : $8.95]

A bioethicists opinion piece in The Hill says FDA needs to expand its reliance on real-world clinical data to monitor the safety a...

Multiple Insightra Medical Violations Cited

[ Price : $8.95]

FDA warns Clarksville, TN-based Insightra Medical about multiple violations in its production of intra-aortic balloon pump cathete...

FDA Study Finds Liver Risks Associated with CBD

[ Price : $8.95]

A new FDA clinical trial finds that cannabidiol may cause liver enzyme elevations in otherwise healthy adults raising new concern...

Expanded Parkinsons Use OKd for Insightec Device

[ Price : $8.95]

FDA approves an expanded indication for Insightecs Exablate Neuro platform for staged bilateral pallidothalamic tractotomy treatme...

Priority Review for Mercks Winrevair

[ Price : $8.95]

FDA accepts and will give priority review to a Merck sBLA for a Winrevair labeling update based on ZENITH trial results.

Vaccine Regulation Now a Political Process: Gottlieb

[ Price : $8.95]

Former FDA commissioner Scott Gottlieb raises significant questions about the current administrations handling of vaccines and vac...

Sandoz Recalls 1 Cefazolin Lot

[ Price : $8.95]

FDA says Sandoz has recalled one lot of Cefazolin for injection following a customer complaint that vials of another drug were inc...

FDA Clears Philips SmartSpeed Precise Software

[ Price : $8.95]

FDA clears Philips SmartSpeed Precise AI-enhanced software for MRI systems.

Myelodysplastic Syndrome Drug Development Guide

[ Price : $8.95]

FDA publishes a draft guidance to assist sponsors in developing drugs to treat myelodysplastic syndromes.